Posts Tagged ‘Improved cardiovascular outcomes’

Rivaroxaban in ACS

Posted by • January 6th, 2012

In a study of patients with acute coronary syndromes, low doses of rivaroxaban were effective in reducing the primary end point of death from cardiovascular causes, myocardial infarction, or stroke. Rivaroxaban also reduced overall mortality, although there was more bleeding.         After an acute coronary syndrome, patients remain at risk for recurrent cardiovascular events despite optimal medical therapy,… Read More…